Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2010-6-7
pubmed:abstractText
Cabergoline is effective for hyperprolactinemic hypogonadism. However, the rate of cabergoline-induced pregnancy in women with prolactinoma remains unknown. Also unknown is whether cabergoline can control tumor growth and thereby achieve successful pregnancy in patients with macroprolactinomas.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1945-7197
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
95
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
2672-9
pubmed:dateRevised
2010-8-2
pubmed:meshHeading
pubmed-meshheading:20357175-Adult, pubmed-meshheading:20357175-Birth Weight, pubmed-meshheading:20357175-Bromocriptine, pubmed-meshheading:20357175-Cohort Studies, pubmed-meshheading:20357175-Dopamine Agonists, pubmed-meshheading:20357175-Drug Resistance, pubmed-meshheading:20357175-Ergolines, pubmed-meshheading:20357175-Female, pubmed-meshheading:20357175-Humans, pubmed-meshheading:20357175-Hyperprolactinemia, pubmed-meshheading:20357175-Infertility, Female, pubmed-meshheading:20357175-Magnetic Resonance Imaging, pubmed-meshheading:20357175-Pituitary Neoplasms, pubmed-meshheading:20357175-Pregnancy, pubmed-meshheading:20357175-Pregnancy Complications, pubmed-meshheading:20357175-Pregnancy Outcome, pubmed-meshheading:20357175-Progesterone, pubmed-meshheading:20357175-Prolactin, pubmed-meshheading:20357175-Prolactinoma
pubmed:year
2010
pubmed:articleTitle
Individualized high-dose cabergoline therapy for hyperprolactinemic infertility in women with micro- and macroprolactinomas.
pubmed:affiliation
Department of Medicine II, Institute of Clinical Endocrinology, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan.
pubmed:publicationType
Journal Article